SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Jul 1, 2019
Document Date
Jul 1, 2019
Form Description
Tender offer schedule and amendment filed by the issuer.
Filing Group
Other
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC